Mendota Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15
Closed -$16.1K 71
2025
Q4
$16.1K Sell
15
-84
-85% -$80.3K 0.01% 83
2025
Q3
$75.5K Hold
99
0.06% 58
2025
Q2
$77.2K Hold
99
0.07% 44
2025
Q1
$81.8K Hold
99
0.09% 40
2024
Q4
$76.4K Sell
99
-44
-31% -$36.4K 0.05% 120
2024
Q3
$127K Sell
143
-135
-49% -$121K 0.06% 104
2024
Q2
$252K Hold
278
0.14% 48
2024
Q1
$216K Sell
278
-196
-41% -$139K 0.13% 54
2023
Q4
$276K Buy
+474
New +$277K 0.22% 48

Other funds holding LLY

Mendota Financial Group's LLY Position: Q1 2026 in Review

Mendota Financial Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 15 shares — an estimated $16.1K sold.

Mendota Financial Group first reported a position in LLY in Q4 2023 and held it in 9 quarters. The position peaked at $276K in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mendota Financial Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Mendota Financial Group sold 15 Eli Lilly shares in Q1 2026, an estimated $16.1K.
  • Mendota Financial Group first reported a position in Eli Lilly in Q4 2023 and held it in 9 quarters.
  • Mendota Financial Group's Eli Lilly position peaked at $276K in Q4 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mendota Financial Group's 13F filing for Q1 2026, filed 16 Apr 2026.